Effectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs (Protocol)

Lucy Platt; Jennifer Reed; Silvia Minozzi; Peter Vickerman; Holly Hagan; Clare French; Ashley Jordan; L Degenhardt; hope vivian; Sharon Hutchinson; Lisa Maher; Norah Palmateer; Avril Taylor; Matthew Hickman

doi:10.1002/14651858.CD012021

Effectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs (Protocol)

Lucy Platt, Jennifer Reed, Silvia Minozzi, Peter Vickerman, Holly Hagan, Clare French, Ashley Jordan, L Degenhardt, hope vivian, Sharon Hutchinson, Lisa Maher, Norah Palmateer, Avril Taylor, Matthew Hickman

Research output: Contribution to journal › Article (Academic Journal) › peer-review

52 Citations (Scopus)

305 Downloads (Pure)

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:
1. To assess the impact of needle/syringe programmes with and without opiate substitution therapy (OST) on the incidence of
HCV infection among people who inject drugs (PWID).
2. To assess the effect of OST alone on the incidence of HCV infection among PWID.
Research questions
1. How effective are needle/syringe programmes (NSP) with and without the use of OST for reducing HCV incidence among
PWID?
2. How effective is OST alone for reducing HCV incidence among PWID?
3. How does the effect of NSP and OST vary according to duration of treatment (i.e. for NSPs weekly attendance versus monthly)?
4. How does the effect of NSP vary according to the type of service (fixed site versus mobile; high coverage versus low coverage)?
5. How does the effect of OST vary according to the dosage of OST, type of substitution used and adherence to treatment?

Original language	English
Article number	CD012021
Number of pages	15
Journal	Cochrane Database of Systematic Reviews
Volume	2016
Issue number	1
DOIs	https://doi.org/10.1002/14651858.CD012021
Publication status	Published - 12 Jan 2016

Access to Document

10.1002/14651858.CD012021

Platt_et_al-2016-The_Cochrane_library_published protocol (2)Final published version, 209 KB

Handle.net

Persistent link

CPRD and Drug Related Mortality
Hickman, M.
1/08/14 → 31/01/17
Project: Research

Cite this

Platt, L., Reed, J., Minozzi, S., Vickerman, P., Hagan, H., French, C., Jordan, A., Degenhardt, L., vivian, H., Hutchinson, S., Maher, L., Palmateer, N., Taylor, A., & Hickman, M. (2016). Effectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs (Protocol). Cochrane Database of Systematic Reviews, 2016(1), [CD012021]. https://doi.org/10.1002/14651858.CD012021

@article{574a4307ec6640218db1922743ced648,

title = "Effectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs (Protocol)",

abstract = "This is the protocol for a review and there is no abstract. The objectives are as follows:1. To assess the impact of needle/syringe programmes with and without opiate substitution therapy (OST) on the incidence ofHCV infection among people who inject drugs (PWID).2. To assess the effect of OST alone on the incidence of HCV infection among PWID.Research questions1. How effective are needle/syringe programmes (NSP) with and without the use of OST for reducing HCV incidence amongPWID?2. How effective is OST alone for reducing HCV incidence among PWID?3. How does the effect of NSP and OST vary according to duration of treatment (i.e. for NSPs weekly attendance versus monthly)?4. How does the effect of NSP vary according to the type of service (fixed site versus mobile; high coverage versus low coverage)?5. How does the effect of OST vary according to the dosage of OST, type of substitution used and adherence to treatment?",

author = "Lucy Platt and Jennifer Reed and Silvia Minozzi and Peter Vickerman and Holly Hagan and Clare French and Ashley Jordan and L Degenhardt and hope vivian and Sharon Hutchinson and Lisa Maher and Norah Palmateer and Avril Taylor and Matthew Hickman",

year = "2016",

month = jan,

day = "12",

doi = "10.1002/14651858.CD012021",

language = "English",

volume = "2016",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

publisher = "Cochrane Collaboration",

number = "1",

}

Platt, L, Reed, J, Minozzi, S, Vickerman, P, Hagan, H, French, C, Jordan, A, Degenhardt, L, vivian, H, Hutchinson, S, Maher, L, Palmateer, N, Taylor, A & Hickman, M 2016, 'Effectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs (Protocol)', Cochrane Database of Systematic Reviews, vol. 2016, no. 1, CD012021. https://doi.org/10.1002/14651858.CD012021

Effectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs (Protocol). / Platt, Lucy; Reed, Jennifer; Minozzi, Silvia et al.
In: Cochrane Database of Systematic Reviews, Vol. 2016, No. 1, CD012021, 12.01.2016.

Research output: Contribution to journal › Article (Academic Journal) › peer-review

TY - JOUR

T1 - Effectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs (Protocol)

AU - Platt, Lucy

AU - Reed, Jennifer

AU - Minozzi, Silvia

AU - Vickerman, Peter

AU - Hagan, Holly

AU - French, Clare

AU - Jordan, Ashley

AU - Degenhardt, L

AU - vivian, hope

AU - Hutchinson, Sharon

AU - Maher, Lisa

AU - Palmateer, Norah

AU - Taylor, Avril

AU - Hickman, Matthew

PY - 2016/1/12

Y1 - 2016/1/12

N2 - This is the protocol for a review and there is no abstract. The objectives are as follows:1. To assess the impact of needle/syringe programmes with and without opiate substitution therapy (OST) on the incidence ofHCV infection among people who inject drugs (PWID).2. To assess the effect of OST alone on the incidence of HCV infection among PWID.Research questions1. How effective are needle/syringe programmes (NSP) with and without the use of OST for reducing HCV incidence amongPWID?2. How effective is OST alone for reducing HCV incidence among PWID?3. How does the effect of NSP and OST vary according to duration of treatment (i.e. for NSPs weekly attendance versus monthly)?4. How does the effect of NSP vary according to the type of service (fixed site versus mobile; high coverage versus low coverage)?5. How does the effect of OST vary according to the dosage of OST, type of substitution used and adherence to treatment?

AB - This is the protocol for a review and there is no abstract. The objectives are as follows:1. To assess the impact of needle/syringe programmes with and without opiate substitution therapy (OST) on the incidence ofHCV infection among people who inject drugs (PWID).2. To assess the effect of OST alone on the incidence of HCV infection among PWID.Research questions1. How effective are needle/syringe programmes (NSP) with and without the use of OST for reducing HCV incidence amongPWID?2. How effective is OST alone for reducing HCV incidence among PWID?3. How does the effect of NSP and OST vary according to duration of treatment (i.e. for NSPs weekly attendance versus monthly)?4. How does the effect of NSP vary according to the type of service (fixed site versus mobile; high coverage versus low coverage)?5. How does the effect of OST vary according to the dosage of OST, type of substitution used and adherence to treatment?

U2 - 10.1002/14651858.CD012021

DO - 10.1002/14651858.CD012021

M3 - Article (Academic Journal)

C2 - 27127417

SN - 1469-493X

VL - 2016

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 1

M1 - CD012021

ER -

Effectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs (Protocol)

Abstract

Access to Document

Handle.net

Fingerprint

Projects

CPRD and Drug Related Mortality

Cite this